Symbols / RMD Stock $203.79 +2.53% ResMed Inc.

Healthcare • Medical Instruments & Supplies • United States • NYQ
RMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Michael J. Farrell BE, MBA, SM
Exch · Country NYQ · United States
Market Cap 29.56B
Enterprise Value 28.74B
Income 1.52B
Sales 5.54B
FCF (ttm) 1.45B
Book/sh 43.39
Cash/sh 11.45
Employees 10,600
Insider 10d —
IPO Jun 02, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 22.47%
P/E 19.65
Forward P/E 16.77
PEG 1.22
P/S 5.34
P/B 4.70
P/C —
EV/EBITDA 13.56
EV/Sales 5.19
Quick Ratio 2.00
Current Ratio 3.01
Debt/Eq 12.99
LT Debt/Eq —
EPS (ttm) 10.37
EPS next Y 12.15
EPS Growth 10.50%
Revenue Growth 10.80%
EPS Gr Q/Q 9.20%
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-04-30
ROA 14.71%
ROE 25.25%
ROIC —
Gross Margin 62.18%
Oper. Margin 35.33%
Profit Margin 27.44%
Shs Outstand 145.06M
Shs Float 144.17M
Insider Own 0.50%
Instit Own 68.62%
Short Float 9.09%
Short Ratio 11.56
Short Interest 11.49M
52W High 293.81
vs 52W High -30.64%
52W Low 198.61
vs 52W Low 2.61%
Beta 0.84
Impl. Vol. 45.31%
Rel Volume 0.97
Avg Volume 1.14M
Volume 1.11M
Target (mean) $270.60
Tgt Median $286.00
Tgt Low $180.00
Tgt High $340.00
# Analysts 15
Recom Buy
Prev Close $198.76
Price $203.79
Change 2.53%
About

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$270.60
Mean price target
2. Current target
$203.79
Latest analyst target
3. DCF / Fair value
$179.51
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$203.79
Low
$180.00
High
$340.00
Mean
$270.60

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-01 main RBC Capital Outperform → Outperform $321
2026-05-01 main Wells Fargo Equal-Weight → Equal-Weight $227
2026-04-27 main Keybanc Overweight → Overweight $290
2026-04-09 main Citigroup Buy → Buy $340
2026-02-02 main Citigroup Buy → Buy $345
2026-01-30 main RBC Capital Outperform → Outperform $314
2026-01-30 main Piper Sandler Neutral → Neutral $275
2026-01-30 main Wells Fargo Equal-Weight → Equal-Weight $270
2026-01-30 main Stifel Hold → Hold $265
2025-12-18 main Stifel Hold → Hold $260
2025-12-16 down Baird Outperform → Neutral $275
2025-11-03 main Baird Outperform → Outperform $300
2025-10-31 main RBC Capital Outperform → Outperform $303
2025-10-31 main Keybanc Overweight → Overweight $299
2025-10-31 main Mizuho Outperform → Outperform $300
2025-10-21 main Morgan Stanley Overweight → Overweight $304
2025-10-13 init Wells Fargo — → Equal-Weight $280
2025-09-18 init Citigroup — → Buy $330
2025-08-01 main Mizuho Outperform → Outperform $290
2025-08-01 main Stifel Hold → Hold $270
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-07 FARRELL MICHAEL J Chief Executive Officer — 4,991 $225.50 $1,125,486
2026-04-07 FARRELL MICHAEL J Chief Executive Officer — 4,991 $146.34 $730,383
2026-04-01 SANDERCOCK BRETT Chief Financial Officer — 1,000 $224.31 $224,310
2026-04-01 FARRELL PETER CRAIG Director — 2,000 $225.00 $450,000
2026-03-09 FARRELL MICHAEL J Chief Executive Officer — 4,991 $251.03 $1,252,902
2026-03-09 FARRELL MICHAEL J Chief Executive Officer — 4,991 $146.34 $730,383
2026-03-04 FARRELL PETER CRAIG Director — 2,000 $260.22 $520,440
2026-03-02 SANDERCOCK BRETT Chief Financial Officer — 1,000 $254.30 $254,300
2026-02-09 FARRELL MICHAEL J Chief Executive Officer — 4,991 $273.78 $1,366,436
2026-02-09 FARRELL MICHAEL J Chief Executive Officer — 4,991 $146.34 $730,383
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
5,146.33
+9.84%
4,685.30
+10.95%
4,222.99
+18.02%
3,578.13
Operating Revenue
5,146.33
+9.84%
4,685.30
+10.95%
4,222.99
+18.02%
3,578.13
Cost Of Revenue
2,091.36
+3.02%
2,029.99
+8.71%
1,867.33
+20.18%
1,553.82
Reconciled Cost Of Revenue
1,900.82
+2.18%
1,860.31
+8.68%
1,711.79
+23.06%
1,391.05
Gross Profit
3,054.97
+15.05%
2,655.30
+12.72%
2,355.66
+16.37%
2,024.31
Operating Expense
1,367.58
+7.58%
1,271.18
+5.61%
1,203.66
+17.76%
1,022.16
Research And Development
331.28
+7.73%
307.52
+6.91%
287.64
+13.43%
253.57
Selling General And Administration
991.02
+8.06%
917.14
+4.94%
874.00
+18.51%
737.51
Total Expenses
3,458.93
+4.78%
3,301.18
+7.50%
3,071.00
+19.22%
2,575.98
Operating Income
1,687.39
+21.91%
1,384.12
+20.15%
1,152.00
+14.95%
1,002.15
Total Operating Income As Reported
1,685.36
+27.69%
1,319.89
+16.61%
1,131.87
+13.15%
1,000.29
EBITDA
1,923.20
+20.18%
1,600.33
+18.58%
1,349.56
+14.70%
1,176.64
Normalized EBITDA
1,925.24
+15.66%
1,664.56
+23.35%
1,349.46
+14.51%
1,178.50
Reconciled Depreciation
235.81
+9.07%
216.21
+9.44%
197.56
+1.92%
193.84
EBIT
1,687.39
+21.91%
1,384.12
+20.15%
1,152.00
+17.22%
982.79
Total Unusual Items
-2.03
+96.84%
-64.23
-63692.08%
0.10
+105.42%
-1.86
Total Unusual Items Excluding Goodwill
-2.03
+96.84%
-64.23
-63692.08%
0.10
+105.42%
-1.86
Special Income Charges
-2.03
+96.84%
-64.23
-63692.08%
0.10
+105.42%
-1.86
Other Special Charges
—
—
-20.23
—
Restructuring And Mergern Acquisition
2.03
-96.84%
64.23
+219.13%
20.13
+979.72%
1.86
Net Income
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Pretax Income
1,677.57
+32.64%
1,264.80
+14.81%
1,101.66
+14.70%
960.48
Net Non Operating Interest Income Expense
4.11
+109.00%
-45.71
+3.53%
-47.38
-112.35%
-22.31
Interest Expense Non Operating
—
45.71
-3.53%
47.38
+112.35%
22.31
Net Interest Income
4.11
+109.00%
-45.71
+3.53%
-47.38
-112.35%
-22.31
Interest Expense
—
45.71
-3.53%
47.38
+112.35%
22.31
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
-13.94
+81.06%
-73.61
-2392.04%
-2.95
+84.74%
-19.36
Other Non Operating Income Expenses
-5.26
-50.43%
-3.49
+38.83%
-5.71
-278.67%
3.20
Gain On Sale Of Security
—
-4.04
-140.77%
9.92
+181.31%
-12.20
Tax Provision
276.84
+13.53%
243.85
+19.47%
204.11
+12.74%
181.05
Tax Rate For Calcs
0.00
-14.51%
0.00
+4.17%
0.00
-1.45%
0.00
Tax Effect Of Unusual Items
-0.34
+97.30%
-12.40
-66344.44%
0.02
+105.34%
-0.35
Net Income Including Noncontrolling Interests
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Net Income From Continuing Operation Net Minority Interest
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Net Income From Continuing And Discontinued Operation
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Net Income Continuous Operations
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Normalized Income
1,402.42
+30.73%
1,072.78
+19.53%
897.47
+14.92%
780.95
Net Income Common Stockholders
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Diluted EPS
—
6.92
+13.63%
6.09
+14.91%
5.30
Basic EPS
—
6.94
+13.40%
6.12
+14.61%
5.34
Basic Average Shares
—
147.02
+0.17%
146.76
+0.48%
146.07
Diluted Average Shares
—
147.55
+0.06%
147.46
+0.28%
147.04
Diluted NI Availto Com Stockholders
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Amortization
45.27
-2.68%
46.52
+10.71%
42.02
+35.21%
31.08
Amortization Of Intangibles Income Statement
45.27
-2.68%
46.52
+10.71%
42.02
+35.21%
31.08
Depreciation Amortization Depletion Income Statement
45.27
-2.68%
46.52
+10.71%
42.02
+35.21%
31.08
Depreciation And Amortization In Income Statement
45.27
-2.68%
46.52
+10.71%
42.02
+35.21%
31.08
Earnings From Equity Interest
-6.66
-12.93%
-5.89
-321.79%
2.66
+112.84%
-20.69
Total Other Finance Cost
-4.11
-109.00%
45.71
-3.53%
47.38
+112.35%
22.31
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
8,174.39
+18.95%
6,872.39
+1.79%
6,751.71
+32.49%
5,095.85
Current Assets
3,505.61
+48.69%
2,357.72
-0.43%
2,367.83
+22.59%
1,931.48
Cash Cash Equivalents And Short Term Investments
1,209.45
+407.40%
238.36
+4.59%
227.89
-16.74%
273.71
Cash And Cash Equivalents
1,209.45
+407.40%
238.36
+4.59%
227.89
-16.74%
273.71
Receivables
990.67
+13.16%
875.46
+24.19%
704.91
+22.39%
575.95
Accounts Receivable
939.49
+12.21%
837.27
+18.78%
704.91
+22.39%
575.95
Gross Accounts Receivable
961.92
+12.06%
858.41
+17.83%
728.51
+21.58%
599.21
Allowance For Doubtful Accounts Receivable
-22.42
-6.11%
-21.13
+10.47%
-23.60
-1.48%
-23.26
Other Receivables
51.17
+34.03%
38.18
—
—
Inventory
927.71
+12.83%
822.25
-17.61%
998.01
+34.16%
743.91
Raw Materials
367.28
+3.29%
355.57
-22.56%
459.13
+29.25%
355.23
Work In Process
2.55
-6.01%
2.71
-31.42%
3.96
+28.57%
3.08
Finished Goods
557.88
+20.24%
463.97
-13.27%
534.93
+38.72%
385.61
Prepaid Assets
213.28
-23.78%
279.82
+8.84%
257.09
+24.41%
206.64
Other Current Assets
164.50
+15.98%
141.83
-21.17%
179.93
+37.07%
131.26
Total Non Current Assets
4,668.79
+3.41%
4,514.68
+2.98%
4,383.88
+38.54%
3,164.38
Net PPE
718.29
+2.74%
699.15
+5.01%
665.81
+5.60%
630.50
Gross PPE
1,423.60
-0.18%
1,426.11
+6.92%
1,333.82
+5.56%
1,263.61
Accumulated Depreciation
-705.31
+2.98%
-726.97
-8.83%
-668.01
-5.51%
-633.11
Properties
0.00
0.00
0.00
0.00
Land And Improvements
51.68
-0.57%
51.98
-0.15%
52.05
+0.37%
51.86
Buildings And Improvements
230.63
-0.19%
231.06
+0.02%
231.02
+0.66%
229.50
Machinery Furniture Equipment
728.61
-4.44%
762.49
+6.55%
715.60
+7.83%
663.63
Other Properties
288.62
+3.64%
278.48
+14.29%
243.65
+2.48%
237.75
Leases
124.05
+21.49%
102.10
+11.59%
91.50
+13.16%
80.86
Goodwill And Other Intangible Assets
3,511.54
+5.52%
3,327.96
+0.16%
3,322.64
+45.58%
2,282.39
Goodwill
3,046.68
+7.20%
2,842.05
+2.59%
2,770.30
+43.06%
1,936.44
Other Intangible Assets
464.86
-4.33%
485.90
-12.03%
552.34
+59.66%
345.94
Non Current Deferred Assets
253.12
+24.34%
203.57
+53.09%
132.97
+66.75%
79.75
Non Current Deferred Taxes Assets
253.12
+24.34%
203.57
+53.09%
132.97
+66.75%
79.75
Non Current Prepaid Assets
—
—
—
171.75
Other Non Current Assets
185.84
-34.56%
284.00
+8.21%
262.45
+52.81%
171.75
Total Liabilities Net Minority Interest
2,206.53
+9.87%
2,008.35
-23.40%
2,621.80
+51.10%
1,735.10
Current Liabilities
1,019.12
+11.91%
910.65
+20.05%
758.53
+10.04%
689.30
Payables And Accrued Expenses
809.99
+12.77%
718.27
+24.04%
579.08
+5.88%
546.91
Payables
446.01
+19.81%
372.26
+50.95%
246.62
+7.00%
230.48
Accounts Payable
278.16
+17.01%
237.73
+57.69%
150.76
-5.33%
159.25
Current Accrued Expenses
363.97
+5.19%
346.01
+4.07%
332.47
+5.07%
316.44
Total Tax Payable
167.86
+24.77%
134.53
+40.34%
95.86
+34.57%
71.23
Income Tax Payable
132.27
+23.03%
107.52
+48.87%
72.22
+60.88%
44.89
Current Debt And Capital Lease Obligation
40.41
+14.86%
35.18
+10.55%
31.82
+0.15%
31.77
Current Debt
9.90
+0.00%
9.90
-0.02%
9.90
-0.14%
9.92
Other Current Borrowings
9.90
+0.00%
9.90
-0.02%
9.90
-0.14%
9.92
Current Capital Lease Obligation
30.51
+20.68%
25.28
+15.32%
21.92
+0.29%
21.86
Current Deferred Liabilities
166.03
+8.83%
152.55
+10.49%
138.07
+27.06%
108.67
Current Deferred Revenue
166.03
+8.83%
152.55
+10.49%
138.07
+27.06%
108.67
Other Current Liabilities
2.69
-42.09%
4.65
-51.31%
9.56
+390.91%
1.95
Total Non Current Liabilities Net Minority Interest
1,187.41
+8.17%
1,097.70
-41.09%
1,863.27
+78.17%
1,045.80
Long Term Debt And Capital Lease Obligation
811.41
-3.26%
838.76
-45.82%
1,548.09
+74.77%
885.78
Long Term Debt
658.39
-5.58%
697.31
-51.28%
1,431.23
+87.01%
765.33
Long Term Capital Lease Obligation
153.01
+8.18%
141.44
+21.04%
116.85
-2.99%
120.45
Tradeand Other Payables Non Current
0.00
0.00
-100.00%
37.18
-23.93%
48.88
Non Current Deferred Liabilities
234.49
+8.22%
216.68
+3.26%
209.84
+99.52%
105.17
Non Current Deferred Revenue
156.80
+14.17%
137.34
+15.23%
119.19
+24.86%
95.45
Non Current Deferred Taxes Liabilities
77.68
-2.09%
79.34
-12.48%
90.65
+833.19%
9.71
Other Non Current Liabilities
141.52
+234.90%
42.26
-38.01%
68.17
+1041.04%
5.97
Stockholders Equity
5,967.86
+22.69%
4,864.04
+17.78%
4,129.90
+22.89%
3,360.75
Common Stock Equity
5,967.86
+22.69%
4,864.04
+17.78%
4,129.90
+22.89%
3,360.75
Capital Stock
0.76
+29.42%
0.59
+0.00%
0.59
+0.34%
0.59
Common Stock
0.76
+29.42%
0.59
+0.00%
0.59
+0.34%
0.59
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
190.31
+0.39%
189.57
+0.35%
188.90
+0.35%
188.25
Ordinary Shares Number
146.39
-0.35%
146.90
-0.11%
147.06
+0.45%
146.41
Treasury Shares Number
43.93
+2.96%
42.66
+1.98%
41.84
+0.00%
41.84
Additional Paid In Capital
2,033.60
+7.22%
1,896.60
+7.03%
1,772.08
+5.33%
1,682.43
Retained Earnings
6,081.49
+21.83%
4,991.65
+17.37%
4,253.02
+17.69%
3,613.74
Gains Losses Not Affecting Retained Earnings
-74.70
+70.30%
-251.53
+7.71%
-272.53
+12.86%
-312.75
Treasury Stock
2,073.29
+16.92%
1,773.27
+9.24%
1,623.26
+0.00%
1,623.26
Other Equity Adjustments
-74.70
+70.30%
-251.53
+7.71%
-272.53
+12.86%
-312.75
Total Equity Gross Minority Interest
5,967.86
+22.69%
4,864.04
+17.78%
4,129.90
+22.89%
3,360.75
Total Capitalization
6,626.25
+19.15%
5,561.36
+0.00%
5,561.14
+34.78%
4,126.08
Working Capital
2,486.49
+71.83%
1,447.06
-10.08%
1,609.30
+29.55%
1,242.18
Invested Capital
6,636.15
+19.11%
5,571.26
+0.00%
5,571.04
+34.70%
4,135.99
Total Debt
851.81
-2.53%
873.93
-44.68%
1,579.91
+72.19%
917.55
Net Debt
—
468.85
-61.36%
1,213.24
+141.91%
501.53
Capital Lease Obligations
183.52
+10.08%
166.72
+20.14%
138.77
-2.49%
142.31
Net Tangible Assets
2,456.32
+59.91%
1,536.08
+90.28%
807.26
-25.14%
1,078.37
Tangible Book Value
2,456.32
+59.91%
1,536.08
+90.28%
807.26
-25.14%
1,078.37
Interest Payable
8.64
-6.13%
9.21
-1.80%
9.38
+17.44%
7.98
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
1,751.59
+25.00%
1,401.26
+102.11%
693.30
+97.44%
351.15
Cash Flow From Continuing Operating Activities
1,751.59
+25.00%
1,401.26
+102.11%
693.30
+97.44%
351.15
Net Income From Continuing Operations
1,400.72
+37.20%
1,020.95
+13.75%
897.56
+15.15%
779.44
Depreciation Amortization Depletion
235.81
+9.07%
216.21
+9.44%
197.56
+1.92%
193.84
Depreciation
235.81
+9.07%
216.21
+9.44%
197.56
+1.92%
193.84
Depreciation And Amortization
235.81
+9.07%
216.21
+9.44%
197.56
+1.92%
193.84
Other Non Cash Items
—
33.24
+400.81%
-11.05
—
Stock Based Compensation
91.66
+14.31%
80.18
+12.71%
71.14
+9.02%
65.26
Operating Gains Losses
6.66
+12.93%
5.89
+2628.24%
0.22
-98.96%
20.69
Gain Loss On Investment Securities
—
4.04
+140.77%
-9.92
-181.31%
12.20
Change In Working Capital
16.74
-62.63%
44.78
+109.69%
-462.13
+34.73%
-708.08
Change In Receivables
-76.68
+42.89%
-134.28
-26.07%
-106.51
-650.56%
19.35
Changes In Account Receivables
-76.68
+42.89%
-134.28
-26.07%
-106.51
-650.56%
19.35
Change In Inventory
-80.17
-146.55%
172.20
+169.20%
-248.83
+20.16%
-311.68
Change In Prepaid Assets
82.63
+171.72%
-115.21
+16.59%
-138.12
+17.84%
-168.11
Change In Payables And Accrued Expense
90.96
-25.49%
122.07
+289.48%
31.34
+112.66%
-247.63
Change In Payable
—
—
—
-247.63
Change In Account Payable
—
—
—
-247.63
Investing Cash Flow
-200.04
+25.85%
-269.78
+76.74%
-1,159.85
-404.46%
-229.92
Cash Flow From Continuing Investing Activities
-200.04
+25.85%
-269.78
+76.74%
-1,159.85
-404.46%
-229.92
Net PPE Purchase And Sale
-89.86
+9.65%
-99.46
+16.89%
-119.67
+11.25%
-134.84
Purchase Of PPE
-89.86
+9.65%
-99.46
+16.89%
-119.67
+11.25%
-134.84
Capital Expenditure
-100.64
+12.38%
-114.86
+14.29%
-134.00
+14.12%
-156.04
Net Investment Purchase And Sale
39.84
+285.64%
-21.46
-63.90%
-13.10
+57.89%
-31.10
Purchase Of Investment
-6.42
+71.44%
-22.46
+30.30%
-32.23
+14.96%
-37.90
Sale Of Investment
46.26
+4526.10%
1.00
-94.77%
19.13
+181.28%
6.80
Net Business Purchase And Sale
-139.25
-4.33%
-133.46
+86.82%
-1,012.75
-2267.12%
-42.78
Purchase Of Business
-139.25
-4.33%
-133.46
+86.82%
-1,012.75
-2267.12%
-42.78
Net Intangibles Purchase And Sale
-10.78
+30.00%
-15.40
-7.45%
-14.33
+32.42%
-21.20
Purchase Of Intangibles
-10.78
+30.00%
-15.40
-7.45%
-14.33
+32.42%
-21.20
Financing Cash Flow
-606.25
+45.84%
-1,119.29
-364.69%
422.87
+429.44%
-128.36
Cash Flow From Continuing Financing Activities
-606.25
+45.84%
-1,119.29
-364.69%
422.87
+429.44%
-128.36
Net Issuance Payments Of Debt
-40.00
+94.52%
-730.00
-209.77%
665.00
+445.08%
122.00
Issuance Of Debt
0.00
-100.00%
105.00
-90.19%
1,070.00
+271.53%
288.00
Repayment Of Debt
-40.00
+95.21%
-835.00
-106.17%
-405.00
-143.98%
-166.00
Long Term Debt Issuance
0.00
-100.00%
105.00
-90.19%
1,070.00
+271.53%
288.00
Long Term Debt Payments
-40.00
+95.21%
-835.00
-106.17%
-405.00
-143.98%
-166.00
Net Long Term Debt Issuance
-40.00
+94.52%
-730.00
-209.77%
665.00
+445.08%
122.00
Net Common Stock Issuance
-225.59
-132.76%
-96.92
-297.22%
49.14
+3.71%
47.38
Common Stock Payments
-300.02
-100.00%
-150.01
0.00
0.00
Common Stock Dividend Paid
-310.88
-10.12%
-282.32
-9.31%
-258.28
-5.27%
-245.34
Cash Dividends Paid
-310.88
-10.12%
-282.32
-9.31%
-258.28
-5.27%
-245.34
Repurchase Of Capital Stock
-300.02
-100.00%
-150.01
0.00
0.00
Net Other Financing Charges
-29.79
-196.39%
-10.05
+69.54%
-32.99
+37.05%
-52.41
Changes In Cash
945.29
+7655.27%
12.19
+127.91%
-43.67
-512.17%
-7.13
Effect Of Exchange Rate Changes
25.80
+1600.81%
-1.72
+19.93%
-2.15
+85.13%
-14.43
Beginning Cash Position
238.36
+4.59%
227.89
-16.74%
273.71
-7.30%
295.28
End Cash Position
1,209.45
+407.40%
238.36
+4.59%
227.89
-16.74%
273.71
Free Cash Flow
1,650.95
+28.34%
1,286.40
+130.00%
559.30
+186.66%
195.11
Interest Paid Supplemental Data
28.41
-37.83%
45.71
-3.53%
47.38
+112.35%
22.31
Income Tax Paid Supplemental Data
214.01
-23.13%
278.40
+28.37%
216.87
-54.64%
478.12
Common Stock Issuance
74.44
+40.20%
53.09
+8.04%
49.14
+3.71%
47.38
Earnings Losses From Equity Investments
6.66
+12.93%
5.89
+2628.24%
0.22
-98.96%
20.69
Issuance Of Capital Stock
74.44
+40.20%
53.09
+8.04%
49.14
+3.71%
47.38
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category